ADMA BIOLOGICS, INC. Payments for (Proceeds from) Short-term Investments
ADMA BIOLOGICS, INC. (ADMA) reported Payments for (Proceeds from) Short-term Investments of $3.38 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForProceedsFromShortTermInvestments · last filed 2014-11-10
- ADMA BIOLOGICS, INC. payments for (proceeds from) short-term investments for the quarter ending 2014-09-30 was $6.05K.
- ADMA BIOLOGICS, INC. payments for (proceeds from) short-term investments for the quarter ending 2014-06-30 was $4.11M.
- ADMA BIOLOGICS, INC. payments for (proceeds from) short-term investments for the quarter ending 2014-03-31 was -$732.14K.
| Period end | Payments for (Proceeds from) Short-term Investments 3 month | Payments for (Proceeds from) Short-term Investments 6 month | Payments for (Proceeds from) Short-term Investments 9 month |
|---|---|---|---|
| 2014-09-30 | $6.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $4.12M derived: sum of 2 quarters · filed 2014-11-10 | $3.38M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $3.38M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$732.14K 10-Q · filed 2014-05-12 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |